Defebvre L - Search Results

1

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.

Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group. Rascol O, et al. Among authors: defebvre l. Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1. Mov Disord. 2021. PMID: 33792958 Free article. Clinical Trial.

2

Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease: a spatiotemporal study of event-related desynchronization.

Defebvre LJ, Derambure P, Bourriez JL, Cassim F, Guieu JD, Destée A. Defebvre LJ, et al. Mov Disord. 1999 Jul;14(4):634-41. doi: 10.1002/1531-8257(199907)14:4<634::aid-mds1013>3.0.co;2-q. Mov Disord. 1999. PMID: 10435501

3

Executive function differences in multiple system atrophy and Parkinson's disease.

Dujardin K, Defebvre L, Krystkowiak P, Degreef JF, Destee A. Dujardin K, et al. Among authors: defebvre l. Parkinsonism Relat Disord. 2003 Mar;9(4):205-11. doi: 10.1016/s1353-8020(02)00050-0. Parkinsonism Relat Disord. 2003. PMID: 12618055 Clinical Trial.

4

[Management of a parkinsonian patient treated by stimulation of the subthalamic nuclei].

Ozsancak C, Krystkowiak P, Dujardin K, Vérin M, Defebvre L. Ozsancak C, et al. Among authors: defebvre l. Rev Neurol (Paris). 2003 May;159(5 Pt 1):593-7. Rev Neurol (Paris). 2003. PMID: 12773909 French. No abstract available.

5

[The role of MRI in the diagnosis of progressive supranuclear palsy].

Vérin M, Defebvre L, Delmaire C, Rolland Y. Vérin M, et al. Among authors: defebvre l. Rev Neurol (Paris). 2005 Feb;161(2):234-6. doi: 10.1016/s0035-3787(05)85030-1. Rev Neurol (Paris). 2005. PMID: 15798526 French. No abstract available.

6

Characteristics of apathy in Parkinson's disease.

Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destée A, Defebvre L. Dujardin K, et al. Among authors: defebvre l. Mov Disord. 2007 Apr 30;22(6):778-84. doi: 10.1002/mds.21316. Mov Disord. 2007. PMID: 17290451

7

Oral festination in Parkinson's disease: biomechanical analysis and correlation with festination and freezing of gait.

Moreau C, Ozsancak C, Blatt JL, Derambure P, Destee A, Defebvre L. Moreau C, et al. Among authors: defebvre l. Mov Disord. 2007 Jul 30;22(10):1503-1506. doi: 10.1002/mds.21549. Mov Disord. 2007. PMID: 17516477

8

The Lille Apathy Rating Scale: validation of a caregiver-based version.

Dujardin K, Sockeel P, Delliaux M, Destée A, Defebvre L. Dujardin K, et al. Among authors: defebvre l. Mov Disord. 2008 Apr 30;23(6):845-9. doi: 10.1002/mds.21968. Mov Disord. 2008. PMID: 18307266

9

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, Destée A, Bordet R, Defebvre L. Devos D, et al. Among authors: defebvre l. Mov Disord. 2008 Apr 30;23(6):850-7. doi: 10.1002/mds.21966. Mov Disord. 2008. PMID: 18311826 Clinical Trial.

10

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Bensimon G, et al. Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291. Epub 2008 Nov 23. Brain. 2009. PMID: 19029129 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters